Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50 GBX | +0.60% | 0.00% | -13.19% |
Apr. 24 | Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results | CI |
Apr. 22 | Capital & Regional picks Gerry Murphy as non-exec director | AN |
Sales 2023 * | 23.99M 30M | Sales 2024 * | 27.18M 33.97M | Capitalization | 109M 136M |
---|---|---|---|---|---|
Net income 2023 * | 15M 18.75M | Net income 2024 * | 19M 23.75M | EV / Sales 2023 * | 10.8 x |
Net Debt 2023 * | 150M 187M | Net Debt 2024 * | 153M 191M | EV / Sales 2024 * | 9.62 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 350 |
Yield 2023 * |
11.4% | Yield 2024 * |
12.1% | Free-Float | 18.71% |
Latest transcript on Capital & Regional plc
1 day | +0.60% | ||
Current month | -3.66% | ||
1 month | -2.72% | ||
3 months | -10.07% | ||
6 months | -6.19% | ||
Current year | -13.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 17-06-12 | |
Stuart Wetherly
DFI | Director of Finance/CFO | - | 12-09-30 |
Sara Jennings
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leon Sasse
BRD | Director/Board Member | 59 | 19-12-08 |
Ian Krieger
BRD | Director/Board Member | - | 14-11-30 |
Laura Whyte
BRD | Director/Board Member | - | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 50 | +0.60% | 36 507 |
24-04-25 | 49.7 | -0.60% | 122,079 |
24-04-24 | 50 | +0.10% | 24,665 |
24-04-23 | 49.95 | -0.10% | 205,587 |
24-04-22 | 50 | 0.00% | 248,802 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.19% | 136M | |
+0.25% | 46.5B | |
-13.21% | 12.42B | |
-22.69% | 11.06B | |
-12.27% | 10.89B | |
-5.17% | 7.5B | |
-6.17% | 6.56B | |
-8.07% | 5.83B | |
-7.60% | 5.73B | |
-6.41% | 4.7B |
- Stock Market
- Equities
- CAL Stock